Alkem Laboratories disclosed CEO Dr. Vikas Gupta's resignation under SEBI LODR Regulation 30(2).
Dr. Gupta will continue until June 30, 2026, to ensure a smooth transition of responsibilities.
The resignation was submitted to pursue new professional opportunities, as per the formal disclosure.